CDH11 and cancer: A previous study demonstrated the potential of CXB, a non‐steroidal anti‐inflammatory drug, to bind and inhibit CDH11, thereby effectively suppressing the cell invasion and migration.[34, 35, 36] However, it is important to note that CXB is primarily utilized as an anti‐Cyclooxygenase‐2 (COX‐2) agent in cancer treatment.